Suppr超能文献

DNA损伤时复制叉的减速与逆转需要PCNA多聚泛素化及ZRANB3 DNA转位酶活性。

Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity.

作者信息

Vujanovic Marko, Krietsch Jana, Raso Maria Chiara, Terraneo Nastassja, Zellweger Ralph, Schmid Jonas A, Taglialatela Angelo, Huang Jen-Wei, Holland Cory L, Zwicky Katharina, Herrador Raquel, Jacobs Heinz, Cortez David, Ciccia Alberto, Penengo Lorenza, Lopes Massimo

机构信息

Institute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.

Department of Genetics and Development, Columbia University Irving Medical Center, Irving Cancer Research Center, New York, NY 10032, USA.

出版信息

Mol Cell. 2017 Sep 7;67(5):882-890.e5. doi: 10.1016/j.molcel.2017.08.010.

Abstract

DNA damage tolerance during eukaryotic replication is orchestrated by PCNA ubiquitination. While monoubiquitination activates mutagenic translesion synthesis, polyubiquitination activates an error-free pathway, elusive in mammals, enabling damage bypass by template switching. Fork reversal is driven in vitro by multiple enzymes, including the DNA translocase ZRANB3, shown to bind polyubiquitinated PCNA. However, whether this interaction promotes fork remodeling and template switching in vivo was unknown. Here we show that damage-induced fork reversal in mammalian cells requires PCNA ubiquitination, UBC13, and K63-linked polyubiquitin chains, previously involved in error-free damage tolerance. Fork reversal in vivo also requires ZRANB3 translocase activity and its interaction with polyubiquitinated PCNA, pinpointing ZRANB3 as a key effector of error-free DNA damage tolerance. Mutations affecting fork reversal also induced unrestrained fork progression and chromosomal breakage, suggesting fork remodeling as a global fork slowing and protection mechanism. Targeting these fork protection systems represents a promising strategy to potentiate cancer chemotherapy.

摘要

真核生物复制过程中的DNA损伤耐受是由增殖细胞核抗原(PCNA)泛素化精心调控的。单泛素化激活易错的跨损伤合成,而多聚泛素化激活一条在哺乳动物中难以捉摸的无差错途径,通过模板转换实现损伤绕过。在体外,叉形结构逆转由多种酶驱动,包括DNA转位酶ZRANB3,该酶已被证明能结合多聚泛素化的PCNA。然而,这种相互作用在体内是否促进叉形结构重塑和模板转换尚不清楚。在这里,我们表明哺乳动物细胞中损伤诱导的叉形结构逆转需要PCNA泛素化、UBC13和K63连接的多聚泛素链,这些以前参与无差错的损伤耐受。体内的叉形结构逆转还需要ZRANB3转位酶活性及其与多聚泛素化PCNA的相互作用,这确定了ZRANB3是无差错DNA损伤耐受的关键效应因子。影响叉形结构逆转的突变也会导致不受控制的叉形结构进展和染色体断裂,这表明叉形结构重塑是一种全局的叉形结构减速和保护机制。靶向这些叉形结构保护系统是增强癌症化疗效果的一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a74f/5594246/979c3294fae1/fx1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验